Skip to content
  • Follow Us
CarboHyde
  • Home
  • CarboHyde’s Cyclodextrin Masterclass XII
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Carbohydrate Chronicles Podcast
    • Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
    • Carbohydrate Chronicles Season 2 / Ep 5 Cyclodextrins to improve sport performance
    • Carbohydrate Chronicles Season 2 / Ep 6 Cyclodextrins in 3D printing
    • Carbohydrate Chronicles Season 2 / Ep 7 Cyclodextrin complex in the making
    • Carbohydrate Chronicles Season 2 / Ep 8 How can cyclodextrins enhance solubility?
    • Carbohydrate Chronicles Season 2 / Ep 9 Curcumin and Cyclodextrin Synergy
    • Carbohydrate Chronicles Season 2 / Ep 10 The Hidden Market Power of Cyclodextrins
  • Home
  • CarboHyde’s Cyclodextrin Masterclass XII
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Carbohydrate Chronicles Podcast
    • - Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • - Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • - Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • - Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
    • - Carbohydrate Chronicles Season 2 / Ep 5 Cyclodextrins to improve sport performance
    • - Carbohydrate Chronicles Season 2 / Ep 6 Cyclodextrins in 3D printing
    • - Carbohydrate Chronicles Season 2 / Ep 7 Cyclodextrin complex in the making
    • - Carbohydrate Chronicles Season 2 / Ep 8 How can cyclodextrins enhance solubility?
    • - Carbohydrate Chronicles Season 2 / Ep 9 Curcumin and Cyclodextrin Synergy
    • - Carbohydrate Chronicles Season 2 / Ep 10 The Hidden Market Power of Cyclodextrins
CarboHyde
  • Home
  • CarboHyde’s Cyclodextrin Masterclass XII
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Carbohydrate Chronicles Podcast
    • Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
    • Carbohydrate Chronicles Season 2 / Ep 5 Cyclodextrins to improve sport performance
    • Carbohydrate Chronicles Season 2 / Ep 6 Cyclodextrins in 3D printing
    • Carbohydrate Chronicles Season 2 / Ep 7 Cyclodextrin complex in the making
    • Carbohydrate Chronicles Season 2 / Ep 8 How can cyclodextrins enhance solubility?
    • Carbohydrate Chronicles Season 2 / Ep 9 Curcumin and Cyclodextrin Synergy
    • Carbohydrate Chronicles Season 2 / Ep 10 The Hidden Market Power of Cyclodextrins

Month: November 2022

Ribitol phosphate and therapeutic strategy of muscular dystrophy

Nov 9, 2022Tamas Sohajdacarbohydrates, drug development, drug discoverymusculoskeletal

The history of ribitol phosphate discovery and the therapeutic strategies currently proposed for musculardystrophy by Motoi Kanagawa from Ehime University

Full article: https://glycoforum.gr.jp/article/25A14.html


Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Nov 7, 2022Tamas Sohajdadrug developmentcholesterol, clinical trial, cyclodextrin, rare disease

Cyclo Therapeutics, Inc. (Caroline Hastings, Benny Liu, Bryan Hurst, Gerald Cox and Sharon Hrynkow) Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Artikle: https://www.sciencedirect.com/science/article/pii/S109671922200419X

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Multivalent glycocyclopeptides: conjugation methods and biological applications

Nov 2, 2022Tamas Sohajdacarbohydratescell, chemistry, peptide, synthesis

Olivier Renaudet, David Goyard, Ángela Martín-Serrano Ortiz and Didier Boturynlick from Université Grenoble Alpes presents click chemistry to decorate synthetic multivalent scaffolds with glycans to mimic the cell surface glycocalyx and to develop applications in glycosciences.

Read the full article

Posts pagination

Previous 1 … 3 4
The main author of the blog is Tamas Sohajda

Subscribe to our blog's newsletter

Categories

  • carbohydrates
  • drug delivery
  • drug development
  • drug discovery
  • education
  • Egyéb kategória
  • news
  • Non-pharma applications
  • Today's cyclodextrin

Archive

  • February 2026 (1)
  • January 2026 (9)
  • December 2025 (6)
  • November 2025 (12)
  • October 2025 (9)
  • September 2025 (24)
  • August 2025 (19)
  • July 2025 (2)
  • June 2025 (13)
  • May 2025 (25)
  • April 2025 (11)
  • March 2025 (16)
  • February 2025 (16)
  • January 2025 (21)
  • December 2024 (8)
  • November 2024 (12)
  • October 2024 (21)
  • September 2024 (10)
  • August 2024 (8)
  • July 2024 (16)
  • June 2024 (12)
  • May 2024 (13)
  • April 2024 (13)
  • March 2024 (13)
  • February 2024 (12)
  • January 2024 (16)
  • December 2023 (7)
  • November 2023 (19)
  • October 2023 (15)
  • September 2023 (18)
  • August 2023 (16)
  • July 2023 (26)
  • June 2023 (19)
  • May 2023 (40)
  • April 2023 (33)
  • March 2023 (47)
  • February 2023 (34)
  • January 2023 (31)
  • December 2022 (23)
  • November 2022 (33)
  • October 2022 (38)
  • September 2022 (9)

Latest posts

  • New patent from Clinch Bioscience
  • CarboHyde wins Eurostars to develop a novel Alzheimer’s drug
  • New year, new Masterclass!

alzheimers analytical chemistry anticancer antiviral bicyclos cancer cancer research carbohyde cardiovascular chemistry cholesterol clinical trial conference covid19 cyclodextrin formulation development genegut gene therapy glycotime infectious diseases monoclonal antibodies polymer rare disease synthesis webinar

Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter
  • Privacy Policy